Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Does Physical Activity Change Over 24 Months in Persons With Relapsing-Remitting Multiple Sclerosis?
Natalizumab discontinuation in the increasing complexity of multiple sclerosis therapy.
Different Mechanisms of Inflammation Induced in Virus and Autoimmune-Mediated Models of Multiple Sclerosis in C57BL6 Mice.
Acute disseminated encephalomyelitis in two renal transplant patients: is there a role for Epstein-Barr virus reactivation?
Alemtuzumab and Multiple Sclerosis: Another Note of Caution.
Palmoplantar Keratoderma and Charcot-Marie-Tooth: combination of two independent genetic diseases? Identification of two point mutations in CMT2 and PPK genes by whole exome sequencing.
Autonomic dysfunction, immune regulation, and multiple sclerosis.
Interaction Study of Phospholipid Membranes with an N-Glucosylated β-Turn Peptide Structure Detecting Autoantibodies Biomarkers of Multiple Sclerosis.
Assessment of Autonomic Dysfunction in Childhood Guillain-Barré Syndrome.
Restriction genes for retroviruses influence the risk of multiple sclerosis.
Multiple sclerosis: potential risk factors in childhood and adolescence.
The polarity protein scribble regulates myelination and remyelination in the central nervous system.
Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis.
Axonal excitability in X-linked dominant Charcot Marie Tooth disease.
Charles bonnet syndrome after herpes simplex encephalitis.
Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications.
Diaphragm Breathing Movement Measurement using Ultrasound and Radiographic Imaging: A Concurrent Validity.
Detection of varicella-zoster virus DNA during medullary and brainstem relapses in multiple sclerosis.
Characteristics of demyelinating Charcot-Marie-Tooth disease with concurrent diabetes mellitus.
[Future issues of the multiple sclerosis treatment from a medical economic viewpoint].
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.
Yoga effects on physical activity and sexual satisfaction among the Iranian women with multiple sclerosis: a randomized controlled trial.
Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia.
Pages
« first
‹ previous
…
652
653
654
655
656
657
658
659
660
…
next ›
last »